drugset / Trial / NCT03466801

The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.

NCT03466801

Terminated 6 enrolled Wenhu Liu
RandomizedParallel-groupOpen-labelTreatment

Summary

Multi-center, prospective, randomized, controlled study to verify the efficacy of prednisone alone and combination therapy with methylprednisolone and cyclophosphamide in the treatment of stage I membranous nephropathy.

Timeline

Start
2018-03-20
Primary completion
2019-01-30
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclophosphamide Other / unclassified 100 mg Oral
Comparator Methylprednisolone Other / unclassified 0.4 mg/kg Other
Subject Prednisone Other / unclassified 1 mg/kg Oral